Karissa Whiting, MS

Memorial Sloan Kettering Cancer Center
New York, New York, United States

Disclosure information not submitted.

Presentation(s):

• Paper 41 - PDGFRβ AND C-ABL ACTIVATION ASSOCIATE WITH OUTCOME AND RESPONSE TO SORAFENIB IN DESMOID PATIENTS TREATED ON THE PHASE III ALLIANCE A091105 TRIAL

  Friday, November 3, 2023
  11:30 AM – 12:30 PM  

• Paper 81 - HISTOLOGIC SUBVARIANTS OF RETROPERITONEAL WELL-DIFFERENTIATED LIPOSARCOMA SHOW EVIDENCE OF CLINICAL AND GENOMIC PROGRESSION TOWARD DEDIFFERENTIATED LIPOSARCOMA

  Saturday, November 4, 2023
  2:00 PM – 3:00 PM